These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Advances in leprosy control in the last 100 years. Bechelli LM Int J Lepr Other Mycobact Dis; 1973; 41(3):285-97. PubMed ID: 4591732 [No Abstract] [Full Text] [Related]
7. WHO experience in the therapeutic control of leprosy. Bechelli LM Int J Lepr Other Mycobact Dis; 1971; 39(4):885-9. PubMed ID: 5170476 [No Abstract] [Full Text] [Related]
8. Bacteriology and pathological study of leprous lesions in the footpads of mice. Job CK Indian J Pathol Bacteriol; 1970 Jul; 13(3):109-11. PubMed ID: 4944997 [No Abstract] [Full Text] [Related]
9. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411 [No Abstract] [Full Text] [Related]
10. An appraisal of medical research in the treatment and control of leprosy. Rees RJ Lepr India; 1982 Oct; 54(4):783-800. PubMed ID: 6763969 [No Abstract] [Full Text] [Related]
12. The effect of neonatal thymectomy on Mycobacterium leprae infection in mice. Su DW; Yang HY; Skinsnes OK Int J Lepr Other Mycobact Dis; 1973; 41(1):81-93. PubMed ID: 4582839 [No Abstract] [Full Text] [Related]
13. WHO regional strategy for sustaining leprosy services and further reducing the burden of leprosy, 2006-2010. WHO Regional Office for South-East Asia Indian J Lepr; 2006; 78(1):33-47. PubMed ID: 16646282 [No Abstract] [Full Text] [Related]
14. WHO global strategy for further reducing the leprosy burden and sustaining leprosy control activities (Plan period: 2006-2010). World Health Organization Indian J Lepr; 2006; 78(1):7-31. PubMed ID: 16646281 [No Abstract] [Full Text] [Related]
15. The use of GIS in leprosy control. Bakker MI; Scheelbeek PF; Van Beers SM Lepr Rev; 2009 Sep; 80(3):327-31. PubMed ID: 19961106 [No Abstract] [Full Text] [Related]
16. Problems requiring solution through field studies. Guinto RS Int J Lepr; 1965; 33(3):Suppl:732-8. PubMed ID: 5322712 [No Abstract] [Full Text] [Related]
17. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980]. Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000 [No Abstract] [Full Text] [Related]
18. Combined rifampin and dapsone chemotherapy of Mycobacterium leprae infection of the neonatally thymectomized Lewis rat. Fieldsteel AH; Levy L Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):267-76. PubMed ID: 7002811 [TBL] [Abstract][Full Text] [Related]
19. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
20. The WHO leprosy programme. Sansarricq H Ann Microbiol (Paris); 1982; 133(1):5-12. PubMed ID: 7051930 [No Abstract] [Full Text] [Related] [Next] [New Search]